These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2883990)

  • 1. Levobunolol and metipranolol: comparative ocular hypotensive efficacy, safety, and comfort.
    Krieglstein GK; Novack GD; Voepel E; Schwarzbach G; Lange U; Schunck KP; Lue JC; Glavinos EP
    Br J Ophthalmol; 1987 Apr; 71(4):250-3. PubMed ID: 2883990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Local subjective tolerance of levobunolol and metipranolol in a double-blind comparative study in patients with increased intraocular pressure].
    Ober M; Scharrer A; Novack GD; Lue JC
    Ophthalmologica; 1986; 192(3):159-64. PubMed ID: 2873545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of once-daily levobunolol for glaucoma therapy.
    Rakofsky SI; Lazar M; Almog Y; LeBlanc RP; Mann C; Orr A; Lee PF; Friedland BR; Novack GD; Kelley EP
    Can J Ophthalmol; 1989 Feb; 24(1):2-6. PubMed ID: 2653592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the ocular hypotensive efficacy of once-daily and twice-daily levobunolol treatment.
    Rakofsky SI; Melamed S; Cohen JS; Slight JR; Spaeth G; Lewis RA; Zbrowski-Gutman L; Eto CY; Lue JC; Novack GD
    Ophthalmology; 1989 Jan; 96(1):8-11. PubMed ID: 2645553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term ocular hypotensive effect of levobunolol: results of a one-year study.
    Ober M; Scharrer A; David R; Biedner BZ; Novack GD; Lue JC; Robins DS; Duzman E
    Br J Ophthalmol; 1985 Aug; 69(8):593-9. PubMed ID: 3893528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levobunolol. A three-month efficacy study in the treatment of glaucoma and ocular hypertension.
    Bensinger RE; Keates EU; Gofman JD; Novack GD; Duzman E
    Arch Ophthalmol; 1985 Mar; 103(3):375-8. PubMed ID: 3883971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of twice-daily levobunolol in the treatment of elevated intraocular pressure.
    Seamone C; LeBlanc R; Saheb N; Novack G
    Can J Ophthalmol; 1988 Jun; 23(4):168-70. PubMed ID: 3293726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levobunolol. A four-year study of efficacy and safety in glaucoma treatment. The Levobunolol Study Group.
    Ophthalmology; 1989 May; 96(5):642-5. PubMed ID: 2664628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of the effectiveness and safety of levobunolol and timolol in ocular hypertension and chronic open-angle glaucoma].
    Freyler H; Novack GD; Menapace R; Skorpik C; Mordaunt J; Batoosingh AL
    Klin Monbl Augenheilkd; 1988 Sep; 193(3):257-60. PubMed ID: 3070134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levobunolol and betaxolol. A double-masked controlled comparison of efficacy and safety in patients with elevated intraocular pressure.
    Long DA; Johns GE; Mullen RS; Bowe RG; Alexander D; Epstein DL; Weiss MJ; Masi RJ; Charap AD; Eto CY
    Ophthalmology; 1988 Jun; 95(6):735-41. PubMed ID: 3062529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the ocular hypotensive efficacy and systemic safety of 0.5% levobunolol and 2% carteolol.
    Behrens-Baumann W; Kimmich F; Walt JG; Lue J
    Ophthalmologica; 1994; 208(1):32-6. PubMed ID: 8145982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular metipranolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in glaucoma and ocular hypertension.
    Battershill PE; Sorkin EM
    Drugs; 1988 Nov; 36(5):601-15. PubMed ID: 2905641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study of levobunolol and timolol in the treatment of chronic open-angle glaucoma and chronic ocular hypertension].
    Savelsbergh-Fillette MP; Demailly P
    J Fr Ophtalmol; 1988; 11(8-9):587-90. PubMed ID: 2906644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levobunolol compared with timolol for the long-term control of elevated intraocular pressure.
    Berson FG; Cohen HB; Foerster RJ; Lass JH; Novack GD; Duzman E
    Arch Ophthalmol; 1985 Mar; 103(3):379-82. PubMed ID: 3883972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of varying drop size on the efficacy and safety of a topical beta blocker.
    Charap AD; Shin DH; Petursson G; Cinotti D; Wortham E; Brown RH; Silverstone DE; Atkins JM; Eto CY; Lue JC
    Ann Ophthalmol; 1989 Sep; 21(9):351-7. PubMed ID: 2683937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the efficacy and tolerability of 0.5% timolol maleate ophthalmic gel-forming solution QD and 0.5% levobunolol hydrochloride BID in patients with ocular hypertension or open-angle glaucoma.
    Halper LK; Johnson-Pratt L; Dobbins T; Hartenbaum D
    J Ocul Pharmacol Ther; 2002 Apr; 18(2):105-13. PubMed ID: 12002664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimum concentration of levobunolol required to control intraocular pressure in patients with primary open-angle glaucoma or ocular hypertension.
    Long D; Zimmerman T; Spaeth G; Novack G; Burke PJ; Duzman E
    Am J Ophthalmol; 1985 Jan; 99(1):18-22. PubMed ID: 3881033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of once-daily levobunolol 0.25% and timolol 0.25% therapy for increased intraocular pressure.
    Silverstone D; Zimmerman T; Choplin N; Mundorf T; Rose A; Stoecker J; Kelley E; Lue J
    Am J Ophthalmol; 1991 Jul; 112(1):56-60. PubMed ID: 1882923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term evaluation of 0.25% levobunolol and timolol for therapy for elevated intraocular pressure.
    Boozman FW; Carriker R; Foerster R; Allen RC; Novack GD; Batoosingh AL
    Arch Ophthalmol; 1988 May; 106(5):614-8. PubMed ID: 3282501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levobunolol. A beta-adrenoceptor antagonist effective in the long-term treatment of glaucoma. The Levobunolol Study Group (Appended).
    Ophthalmology; 1985 Sep; 92(9):1271-6. PubMed ID: 2865710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.